StonvexLoading…
StonvexStonvexStonvexCore line items from OSW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $961.00M | $895.02M | $794.04M | $546.26M |
Operating Income | $81.64M | $78.06M | $54.17M | $15.14M |
Net Income | $71.62M | $72.86M | $-2.97M | $53.16M |
EPS (Diluted) | $0.69 | $0.69 | $-0.03 | $0.49 |
Total Assets | $707.10M | $746.42M | $706.14M | $717.43M |
Total Liabilities | $164.52M | $191.93M | $272.07M | $351.63M |
Cash & Equivalents | $16.31M | $57.44M | $27.70M | $32.06M |
Free Cash Flow OCF − CapEx | $68.45M | $72.06M | $57.96M | $19.94M |
Shares Outstanding | 103.67M | 104.94M | 97.83M | 95.11M |